Ophthalmia neonatorum is a form of bacterial conjunctivitis contracted by newborns during delivery and occurs during the first month of life. Etiologic factors include Neisseria gonorrhoeae, Chlamydia trachomatis, viruses and chemicals. Its prevalence differs in different parts of the world and is dependent mainly upon socioeconomic conditions, level of knowledge about general health, standard of maternal healthcare as well as the type of prophylactic program used. This randomized clinical trial was performed during the years 2004-05 in the Delivery Section of Vali-e-Asr Hospital on 330 neonates who were divided into three equal groups of 110; Group A received betadine eye drops, Group B received Erythromycin eye drops and Group C (control group) received no treatment. Results showed that clinical conjunctivitis occurred in 52 subjects (17%), 58% of whom constituted males. On the whole, 9% of the infected newborns were from group A, 18.4% from group B and 22.4% from group C. It was concluded that 2.5% sterile betadine eye drops had a pronounced effect on ophthalmia neonatorum (p ¼ 0.030).
Introduction
Ophthalmia neonatorum is a form of bacterial conjunctivitis contracted by newborns during delivery and can occur during the first month of life. Etiologic factors include Neisseria gonorrhoeae, Chlamydia trachomatis, viruses and chemicals [1, 2] . Its prevalence differs in different regions of the world and has been reported to range between less than 2% to 23% in developing countries [1, 3] , and is dependent mainly upon socioeconomic conditions, level of knowledge on general health, standard of maternal healthcare as well as the type of prophylactic program used. This important worldwide health problem which affects newborns, is an important cause of morbidity and blindness in children. In Africa alone, around 1000-4000 newborns ultimately develop blindness annually [2, 3] . The severity of this infection ranges from a mild self-limiting conjunctivitis caused by silver nitrate solution (chemical conjunctivitis) to a more severe form caused by Gonococcus and Pseudomonas species in which corneal perforation, blindness, and even death (pyogenic conjunctivitis) may occur [2] . Silver nitrate eye drops, and erythromycin or tetracycline ointments are currently used in the prophylaxis of ophthalmia neonatorum but recently, 2.5% betadine eye drops has also been recommended. Prophylactic therapy should also be considered for newborns who are delivered by cesarean section [3] [4] [5] [6] . The overall rate of infection is 34% higher among newborns who receive silver nitrate than those treated with betadine eye drops. Also, infection rate is 16% higher among newborns who receive erythromycin than those treated with betadine [3] . 2.5% betadine solution has a wide range antimicrobial action which can act against bacteria, chlamydia and viruses, including HIV, Herpes virus type II and does not develop bacterial resistance. It has mild toxic effects and rarely causes chemical conjunctivitis [3] [4] [5] [6] . Betadine is a wide spectrum, effective, cheap and easily available solution and is therefore recommended for use in developing countries. Its tendency to discolor the surface of the eye to a brown color can be used as a helpful indicator for its correct and effective use [3, 4] . Considering that the prevalence of this condition is high in our country (30%) [7] , and that it is associated with grave complications and since there is no defined prophylactic therapeutic program for this disease, thus it is crucial to introduce an effective, practical and feasible method with less adverse effects and cost which is compatible with the conditions of our country. PCR is the most sensitive method used to diagnose chlamydial conjunctivitis. comparable to culture results. In one study, sensitivity, specificity and positive or negative predictivity of PCR was found to be 92.3, 100 and 98.4% in comparison to culture, respectively [8] . In this study, we compare the efficacy of 2.5% betadine, and 0.5% erythromycin eye drops in neonatal conjunctivitis. Inclusion criteria included healthy newborns without congenital eye anomalies, newborns of mothers who had not used any form of antibiotics within the last 48 h prior to delivery, absence of rupture of membranes for more than 18 h, and absence of meconium aspiration. After obtaining written parent consent and completing a questionnaire all newborns who met the above criteria were examined. A total of 330 neonates were placed in three equal groups of 110 by the simple randomization method and without the researcher interference. For prophylaxis of ophthalmia neonatorum, during the first few hours of birth 2.5% sterile betadine drops and 0.5% erythromycine ointment were instilled into the eyes of newborns in group A and group B, respectively; group C (control group) did not receive any form of treatment.
Materials and Method
Neonates present with redness and hyperemia or the presence of purulent ocular discharge. The neonates were then examined on a weekly basis and the parents were advised to bring the child to the hospital clinic in case such findings were observed within 24 h to one month after birth. Once the diagnosis of clinical conjunctivitis was confirmed by a pediatrician, the newborns were referred to the laboratory where a culture and smear were prepared from the ocular discharge and subsequently gram stained for diagnosis of chlamydia or herpes infections. A suitable antibiotic was then started and after obtaining culture results (within 48-72 h), the newborns were reexamined and therapy was continued according to the antibiogram results (infectious conjunctivitis). In case the smear, culture, and PCR results were negative, the conjunctivitis was considered to be chemical in the type. The kit used for PCR detection of chlamydia trachomatis DNA was Lot Number (0104F).
Results
In this study, a total of 330 neonates who were born in the Delivery Section of Vali-e-Asr Hospital from January 2004 through August 2005 were studied after being divided into three equal groups of 110. Group A received 2.5% sterile betadine eye drops, Group B received 0.5% erythromycin ointment and Group C (control group) received no form of treatment. Ten newborns from group A, seven from group B and three from group C, were excluded from the study for various reasons including infection, lack of cooperation or failure to return for follow-up. Therefore, overall 310 newborns were studied, 139 (45%) and 171 (55%) of whom were females and males, respectively. Mean maternal age was 27 AE 5 years and mean number of deliveries was 2 AE 1 and 95% of the mothers had received regular and adequate prenatal care. Of all newborns 52 (17%) were found to have clinical conjunctivitis, of whom 30 (58%) were boys. However, there was no significant statistical relationship between these three groups. Nine subjects from group A, 19 (18.4%) from group B and 24 (22.4%) from group C visited the clinic due to conjunctival redness and tearing or serious or purulent discharge during the first 24 h through 2 weeks of birth and 258 of the neonates were found to be healthy (83%) ( Table 1) . Among the 52 newborns with clinical conjunctivitis, 33(63.5%) and 19 (36.5%) were unilateral and bilateral, respectively. Unilateral conjunctivitis was observed in 18 subjects (75%) in the control group, 11 subjects (58%) in group B and four subjects (44%) in group A (Table 2 ). Mean neonatal body weight was 1500 g and we found no significant association between body weight and clinical conjunctivitis in either group. Conjunctivitis was observed in the first 24 h in 10% of newborns, and was more common in the control group (21%). Most cases (54%) occurred during the second to fourth days of life and 17% occurred during the fifth to seventh days and 19% occurred after the first week of life. There was no significant statistical relationship between development of conjunctivitis and rupture of membranes. 94% of newborns with neonatal conjunctivitis were born to mothers aged between 18 and 35 years. The type of delivery was vaginal in 46% of cases and cesarean section in 167(54%) of cases, 27 (19%) and 25 (15%) of whom developed conjunctivitis, respectively. Sixty-five mothers who delivered vaginally, defecated during the process of delivery but only 15 neonates developed clinical conjunctivitis (p ¼ 0.540). 295 (95%) of the mothers received regular prenatal care. Five (55.6%) newborns with conjunctivitis in group A and four (16.7%) in group C were born to mothers with urinary tract infection, while none of the newborns with conjunctivitis were born to mothers with urinary tract infection in group B (Table 3) . Only 23 (44%) of the neonates with conjunctivitis who were referred to the laboratory actually did so. However, all nine subjects with conjunctivitis in group A, attended the laboratory. Smear and culture results were positive in four cases, three of which revealed gram positive cocci; 2 (50%) Staphylococcus epidermidis, one (25%) Staphlococcus aureus and one (25%) gram positive Bacillus (diphtheroid); this was also positive for PCR Chlamydia (mixed). Smear and culture findings were negative in five cases, one of which was positive for PCR Chlamydia. Therefore in group A, five (5%) newborns had infectious, four (4%) had chemical, two (2%) chlamydial and one (1%) had mixed types of conjunctivitis. In group B, among the 19 cases with clinical conjunctivitis, only seven (37%) attended the laboratory, the smear and culture results of whom were negative (chemical conjunctivitis) in three and positive in four cases, respectively. Also one had mixed conjunctivitis in which PCR Chlamydia was also positive (infectious conjunctivitis). In group C (control group), only seven (29%) newborns with conjunctivitis attended the laboratory, three of whom had negative smear results and four of whom had positive smear and culture results (gram positive cocci). Among the negative smears, one positive culture (S.epidermidis) was seen. Therefore, in the control group five subjects had positive culture findings, PCR Chlamydia was also positive in one case and two cases had negative culture results (chemical conjunctivitis). PCR for Herpes virus was negative in all three groups (Table 4) .
Discussion
In this study, 52 newborns (17%) had clinical conjunctivitis, 58 and 42% of whom were girls and boys, respectively. There was no significant relationship in regard to gender, which is in agreement with other similar studies [7] [8] [9] [10] [11] . Also, there was no relationship between conjunctivitis and neonatal body weight with no significant difference between the three study groups, which is in accordance with other studies [7] [8] [9] [10] [11] . Unilateral conjunctivitis was more common (63.5%) in our study, while bilateral conjunctivitis was more frequent (75.5%) in a similar study. A bilateral tendency was observed in all three groups [11] , however, the difference was not significant in either group. The earliest time at which conjunctivitis occurred was on the first day of birth, which was seen in newborns in the control group (21% neonates) and a similar study showed that the least number of cases occurred within the first day of life. However, most (53.8%) cases occurred between the second and fourth days of life, which is in accordance with similar studies [11] . There was a significant relationship between conjunctivitis and maternal urinary tract infection in all three groups (p ¼ 0.001) and there was also a significant relationship between the betadine and erythromycin groups (p >0.001), however, as compared to the control group, neither of these two groups showed a significant difference which is not in agreement with similar studies [11] . However, in a study performed in Kenya [3] , conjunctivitis was more frequent amongst the neonates of mothers with bacterial infection (p <0.0009). The risk of developing neonatal conjunctivitis depends upon the frequency of maternal urinary tract infection, mode of prophylaxis and the rate of contact with the microorganisms during pregnancy and the first days of life [1] [2] [3] . There was no significant relationship between neonatal conjunctivitis and maternal fecal defecation during the process of delivery. This difference was found to be significant in a study in which all mothers delivered by NVD (p ¼ 0.0001) [12] . Like other studies, we did not find any cases with gonococcal conjunctivitis [1, 4, 7, [12] [13] [14] , but it has been reported in Kenya (5%) and Nigeria (5%) [3, 7] . Also like other studies, we did not find any cases with herpetic conjunctivitis [3, 7, 11, 12, 15] . The types of conjunctivitis found in group A were infectious (5%), chemical (4%) and two chlamydial and two mixed (gram positive bacilli and chlamydia). Similar studies have reported infectious conjunctivitis to be around 5% [7] , 5.8% [12] and 8.2% [14] , and chemical conjunctivitis to be around 1.7% [12] , 10.2% [14] and 12.2% [3] . In another study [12] , Giemsa staining and DFA test and in yet another study [7] , Giemsa staining techniques were used to detect Chlamydia. Chlamydial conjunctivitis was not seen in the betadine group. In the study performed in Kenya, Chlamydia was detected in 50.5% of cases by using Giemsa stain and DFA test [3] . In one study [13] , Chlamydia was detected in 24% of cases using the IFA technique and in another study [14] , Chlamydia was found in 4% of cases using both Giemsa and DFA methods. In our study, we used PCR which is a more sensitive and specific test for detecting chlamydia and is comparable to culture methods [8] [9] [10] . Chlamydia was found in 2% of cases in group A, which mostly included cesarean section deliveries. Different studies have confirmed the advantage of 2.5% betadine eye drop instillation in the prevention of infectious conjunctivitis (bacterial and chlamydial) [11, 12, 14, 15] . In a similar study, a significant number of cases with chemical conjunctivitis were seen after prophylactic treatment with silver nitrate and it was suggested that 2.5% betadine eye drops be used instead because it lowers the rate of chemical conjunctivitis [14] . In our study, gram positive cocci were the most common organisms detected in all three groups. Staphylococcus epidermidis infection accounts for 75% of the conjunctivitis detected in groups A and B and 50% of those detected in group C, which is in concordance with similar studies [7, 13] . In one study the most common organisms were gram positive cocci (50%) and gram negative bacilli (40%) [12] while other studies have reported S. aureus as the most common type of gram positive cocci [3] [4] [5] . Transmission of chlamydia occurs directly through sexual contact or during the process of delivery or indirectly through insects or fomites and it is not limited to the perinatal period and environmental factors may play a major role. The cause of around 8-9% of neonatal conjunctivitis is attributed to chlamydia, but it has been seen that only 3% of mothers have positive cervical culture (1) (2) (3) (4) (5) 16) . Therefore, clamydial infection in neonates born to mothers who were delivered by cesarean section is attributed to environmental factors. Chlamydial and gonococcal conjunctivitis are more frequent in countries where prophylactic treatment is not routine [2] [3] [4] [5] . These studies show that prophylaxis with 2.5% betadine is superior to erythromycin [3, 6, 12, 17] . The 2.5% betadine has a wide spectrum antimicrobial action and can act against bacteria, chlamydia and viruses, including HIV and Herpes virus type II. Also, it does not posses microbial resistance and has mild toxic effects with a very low rate of chemical conjunctivitis [3] [4] [5] [6] .
Conclusion Clinical conjunctivitis is significantly less frequent among newborns who receive prophylactic therapy with 2.5% betadine drops (p ¼ 0.030). Considering the advantages of betadine eye drops (cheap, wide spectrum, lower toxicity, easy to use), it is suggested that the health authorities of Iran should arrange that all neonates receive prophylactic ophthalmic treatment at the time of birth with 2.5% betadine eye drops as the best prophylactic treatment for neonatal conjunctivitis.
